The cost of managing type 2 diabetes mellitus in greece: A retrospective analysis of 10-year patient level data "the HERCULES study"

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Migdalis, Ilias ^a   Rombopoulos, Grigorios ^b   Hatzikou, Magdalini ^b   Manes, Christos ^c   Kypraios, Nikolaos ^d   Tentolouris, Nikolaos ^e  

^a NIMTS HOSPITAL   (Greece)

^b Novartis Hellas 12th Km National Road Athens Lamia   (Greece)

^c Aristotle University and Hippokration General Hospital   (Greece)

^d IASO GENERAL HOSPITAL   (Greece)

^e LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; HEMOGLOBIN A1C; INSULIN; LONG ACTING INSULIN; MEGLITINIDE; SHORT ACTING INSULIN; SULFONYLUREA DERIVATIVE;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; GREECE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SOCIAL STATUS;

EID: 84930676673     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/520759     Document Type: Article

References (27)

1. World Health Organization, "Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia," 2006.
2. World Health Organization, Diabetes: Fact sheet No 312, 2013, http://www.who.int/mediacentre/factsheets/fs312/en/index. html.
3. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 1999.
4. N. Tentolouris, A. Andrianakos, G. Karanikolas et al., "Type 2 diabetes mellitus is associated with obesity, smoking and low socioeconomic status in large and representative samples of rural, urban, and suburban adult Greek populations," Hormones, vol. 11, no. 4, pp. 458-467, 2012.
5. M. Stumvoll, B. J. Goldstein, and T. W. van Haeften, "Type 2 diabetes: principles of pathogenesis and therapy," The Lancet, vol. 365, no. 9467, pp. 1333-1346, 2005.
6. H. King, R. E. Aubert, andW. H. Herman, "Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections," Diabetes Care, vol. 21, no. 9, pp. 1414-1431, 1998.
7. D. B. Panagiotakos, C. Pitsavost, C.Chrysohoout, andC. Stefanadis, "The epidemiology of type 2 diabetes mellitus in Greek adults: the ATTICA study," DiabeticMedicine, vol. 22, no. 11, pp. 1581-1588, 2005.
8. A. Gikas, A. Sotiropoulos, D. Panagiotakos et al., "Rising prevalence of diabetes among Greek adults: findings from two consecutive surveys in the same target population," Diabetes Research and Clinical Practice, vol. 79, no. 2, pp. 325-329, 2008.
9. A.M.Melidonis, S. M. Tournis, M. K. Kompoti et al., "Increased prevalence of diabetes mellitus in a rural Greek population," Rural and Remote Health, vol. 6, no. 1, p. 534, 2006.
10. S.Wild, G. Roglic,A.Green,R. Sicree, andH.King, "Globalprevalence of diabetes: estimates for the year 2000 and projections for 2030," Diabetes Care, vol. 27, no. 5, pp. 1047-1053, 2004.
11. World Health Organization, Obesity 1998: Preventing andManaging the Global Epidemic,WorldHealth Organization, Geneva, Switzerland, 1998.
12. C. L. Ogden, M. D. Carroll, L. R. Curtin, M. A. McDowell, C. J. Tabak, and K.M. Flegal, "Prevalence of overweight and obesity in the United States, 1999-2004," The Journal of the American Medical Association, vol. 295, no. 13, pp. 1549-1555, 2006.
13. The International Diabetes Federation. IDF Diabetes Atlas, 2009.
14. World Health Organization, Global Health Risks. Mortality and Burden of Disease Attributable to Selected Major Risks, World Health Organization, Geneva, Switzerland, 2009.
15. World Health Organization, Global Status Report on Noncommunicable Diseases 2010, 2011.
16. P. Hogan, T. Dall, and P. Nikolov, "Economic costs of diabetes in the US in 2002," Diabetes Care, vol. 26, pp. 917-932, 2003.
17. P.Zimmet, K. G.M.M. Alberti, andJ.Shaw, "Global and societal implications of the diabetes epidemic," Nature, vol. 414, no. 6865, pp. 782-787, 2001.
18. G. Rombopoulos, M. Hatzikou, D. Latsou, and J. Yfantopoulos, "The prevalence of hypoglycemia and its impact on the quality of life (QoL) of type 2 diabetes mellitus patients (The HYPO Study)," Hormones, vol. 12, no. 4, pp. 550-558, 2013.
19. American Diabetes Association, "Economic costs of diabetes in the U.S. In 2007," Diabetes Care, vol. 31, no. 3, pp. 596-615, 2008.
20. B. Jönsson, "Revealing the cost of Type II diabetes in Europe," Diabetologia, vol. 45, no. 6, pp. S5-S12, 2002.
21. S. Jones, C. Castell, A. Goday et al., "Increase in direct diabetesrelated costs and resource use in the 6 months following initiation of insulin in patients with type 2 diabetes in five European countries: data from the INSTIGATE study," ClinicoEconomics and Outcomes Research, vol. 4, no. 1, pp. 383-393, 2012.
22. K. Athanasakis, M. Ollandezos, A. Angeli, A. Gregoriou, M. Geitona, and J. Kyriopoulos, "Estimating the direct cost of type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost," DiabeticMedicine, vol. 27,no. 6, pp. 679-684, 2010.
23. K. Aloumanis, M. Benroubi, S. Sourmeli, and V. Drossinos, "Clinical outcomes and costs for patients with type 2 diabetes mellitus initiating insulin therapy in Greece: two-year experience from the INSTIGATE study," Primary Care Diabetes, vol. 7, no. 3, pp. 235-242, 2013.
24. Greek Ministry of Health, Drug Price Bulletin 05/06/13, 2014, http://www.moh.gov.gr/.
25. Greek Ministry of Health, Diagnosis Related Groups March, 2012, http://www.moh.gov.gr/articles/health/domes-kai-draseis-gia-thn-ygeia/kwdikopoihseis/709-kleista-enopoihmenanoshlia-1.
26. FEK 157/91 issue A, http://www.et.gr/index.php.
27. American Diabetes Association, Economic Costs of Diabetes in the U.S. in 2012. Diabetes Care, American Diabetes Association, Alexandria, Va, USA, 2013.